0001213900-22-014499.txt : 20220323
0001213900-22-014499.hdr.sgml : 20220323
20220323162916
ACCESSION NUMBER: 0001213900-22-014499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220321
FILED AS OF DATE: 20220323
DATE AS OF CHANGE: 20220323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ganjei James Kelly
CENTRAL INDEX KEY: 0001767300
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38793
FILM NUMBER: 22763533
MAIL ADDRESS:
STREET 1: 10609 RIVER OAKS LANE
CITY: POTOMAC
STATE: MD
ZIP: 20859
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inmune Bio, Inc.
CENTRAL INDEX KEY: 0001711754
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475205835
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 8589643720
MAIL ADDRESS:
STREET 1: 1200 PROSPECT STREET
STREET 2: SUITE 525
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2022-03-21
0
0001711754
Inmune Bio, Inc.
INMB
0001767300
Ganjei James Kelly
C/O INMUNE BIO INC.,
225 NE MIZNER BLVD., SUITE 640
BOCA RATON,
FL
33432
1
0
0
0
Common Stock
2022-03-22
4
A
0
17793
8.43
A
17793
D
Option (right to buy)
7.92
2022-03-21
4
A
0
35000
0
A
2032-03-20
Common Stock
35000
35000
D
The purchase price of the common stock being reported is the closing price per share immediately preceding the entering into of the binding agreement to issue the securities. These shares were purchased by the Reporting Person directly from Issuer.
Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.
/s/ James Kelly Ganjei
2022-03-23